Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 3, 2003, Pages 514-517

  Gavaldà, Joan ^a   Onrubia, Pedro López ^a   Gómez, María Teresa Martín ^a   Gomis, Xavier ^a   Ramírez, José Luis ^a   Len, Oscar ^a   Rodríguez, Dolors ^a   Crespo, Manuel ^a   Ruíz, Isabel ^a   Pahissa, Albert ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Animal models; Antibiotic combinations; Bacteria; Intravascular infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; GENTAMICIN; PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL STRAIN; CATHETER; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; ENDOCARDITIS; ENTEROCOCCUS FAECALIS; NEPHROTOXICITY; NONHUMAN; RABBIT; TREATMENT OUTCOME;

AMINOGLYCOSIDES; AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CEFTRIAXONE; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECALIS; GENTAMICINS; HALF-LIFE; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; RABBITS;

EID: 10744227552     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg360     Document Type: Article

References (10)

1. Scheld, W. M. & Sande, M. A. (1995). Endocarditis and intravascular infections. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 740-83. Churchill-Livingstone, New York, NY, USA.
2. Gavaldà J., Torres, C., Tenorio, C. et al. (1999). Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrobial Agents and Chemotherapy 43, 639-46.
3. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA, USA
4. Eliopoulos, G. M. & Moellering, R. C. (1996). Antimicrobial combinations. In Antibiotics in Laboratory Medicine (Lorian, V. Ed.), pp. 330-96. Williams & Wilkins, Baltimore, MA, USA.
5. Gavaldà, J., Cardona, P. J., Capdevila, J. A. et al. (1996). Treatment of experimental endocarditis due to Enterococcus faecalis using a once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrobial Agents and Chemotherapy 40, 173-8.
6. López, P., Gavaldà, J., Martín, M. T. et al. (2001). Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis. Antimicrobial Agents and Chemotherapy 45, 1387-93.
7. Mainardi, J. L., Gutmann, L., Acar, J. F. et al. (1995). Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 39, 1984-7.
8. Join-Lambert, O., Mainardi, J. L., Cuvelier, C. et al. (1998). Critical importance of in vivo amoxicillin and cefotaxime concentrations for synergy in treatment of experimental Enterococcus faecalis endocarditis. Antimicrobial Agents and Chemotherapy 42, 468-70.
9. Gavaldà, J., Miró, J. M., Torres, C. et al. Efficacy of ampicillin (A) plus ceftriaxone (Ctr) or cefotaxime (Cx) in the treatment of endocarditis due to Enterococcus faecalis. In Programs and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2001. Abstract 1342, p. 466. American Society for Microbiology, Washington, DC, USA.
10. Caron, F., Lemeland, J. F., Humbert, G. et al. (1993). Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium. Journal of Infectious Diseases 168, 681-6.